Symposium Genome Editing, Health innovation, and Responsible Regulation

Description

With the recent breakthroughs in genomics and advances in gene-editing techniques, the question of genome-editing and health innovation has become particularly important in society. New techniques such as CRISPR-Cas9 hold considerable potential to enhance personalized medicine. However, their potential and possible applications also bring along complex legal and regulatory questions in the European legal environment, intersecting with ethical and social concerns. How should the law respond to genome editing and health innovation in order to adequately reconcile diverse competing interests at stake and enhance personalized medicine?

Period	2021 Nov 3 → 2021 Nov 4
Event type	Other
Location	Uppsala, SwedenShow on map
Degree of Recognition	International